Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Top Cited Papers
Open Access
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 21 (3), 418-429
- https://doi.org/10.1016/j.ccr.2012.01.007
Abstract
No abstract availableKeywords
Funding Information
- Giles W. and Elise G. Mead Foundation
- National Cancer Institute (CA109552, CA114028, CA152249, CA161112)
This publication has 55 references indexed in Scilit:
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II TrialJournal of Clinical Oncology, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2Cancer Research, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cellsSeminars in Cancer Biology, 2008
- Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?British Journal of Cancer, 2007
- Hyaluronan: from extracellular glue to pericellular cueNature Reviews Cancer, 2004
- Thermodynamic analysis of the permeability of biological membranes to non-electrolytesBiochimica et Biophysica Acta, 1958